Pfizer will ask the Food and Drug Administration to approve its COVID booster for kids ages 5 to 11. In a trial, the additional shot boosted antibodies sixfold when administered six months after the initial two-shot regimen, the company said. (NBC News)
Editas tapped Sarepta Therapeutics CMO Gilmore O’Neill as CEO. He’ll become the company’s third CEO in as many years. (Endpoint News)
Regeneron said that the Food and Drug Administration is still evaluating whether to fully approve its COVID-19 treatment. Regen-Cov is a monoclonal antibody treatment that was authorized in November 2020 to treat COVID-19, but hasn’t been proven effective against new variants. (MarketWatch)
Most voters support price controls on prescription drugs. A national survey found 43% of voters “strongly” favor price controls on prescription drugs, while 29% “somewhat” favor them. (The National Desk)
So-called “pharma influencers” have grown in number and prominence. The surge has led researchers to examine how pharmaceutical companies are partnering with social media influencers willing to share their patient experiences with followers. (MEL Magazine)
